LegalizeThe Genetically Modified Organisms (Contained Use) Regulations 2014
[^key-9c2302bf96cce5b59d9b68559ad85115]: Word in reg. 27(a) inserted (31.12.2020) by The Health and Safety (Amendment) (EU Exit) Regulations 2018 (S.I. 2018/1370), regs. 1(1), 9(3)(a); 2020 c. 1, Sch. 5 para. 1(1)
[^key-7f44db21147662c504127b5118e71452]: Reg. 27(b) omitted (31.12.2020) by virtue of The Health and Safety (Amendment) (EU Exit) Regulations 2018 (S.I. 2018/1370), regs. 1(1), 9(3)(b)(i); 2020 c. 1, Sch. 5 para. 1(1)
[^key-b9316c3c245b1d73e3cfa7cb31953fa3]: Word in reg. 27(c) omitted (31.12.2020) by virtue of The Health and Safety (Amendment) (EU Exit) Regulations 2018 (S.I. 2018/1370), regs. 1(1), 9(3)(b)(ii); 2020 c. 1, Sch. 5 para. 1(1)
[^key-3b197bc3f3ed8283eac168aa5c76d6ae]: Reg. 27(d) omitted (31.12.2020) by virtue of The Health and Safety (Amendment) (EU Exit) Regulations 2018 (S.I. 2018/1370), regs. 1(1), 9(3)(b)(iii); 2020 c. 1, Sch. 5 para. 1(1)
[^key-44773c4a01d138e40debe5bc757d80d1]: Sch. 3 para. 3(d) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 1 para. 40(4); 2020 c. 1, Sch. 5 para. 1(1)
[^key-00b09bb9def9c67d3a273823a76f2264]: Reg. 3(7) inserted (13.11.2025) by The Genetic Technology (Precision Breeding) Regulations 2025 (S.I. 2025/581), reg. 1(1), Sch. 5 para. 13(3)
[^key-fbe083a4fe4d4f95428de03fb0f6748f]: Reg. 3(2)(d) inserted (13.11.2025) by The Genetic Technology (Precision Breeding) Regulations 2025 (S.I. 2025/581), reg. 1(1), Sch. 5 para. 13(2)
Transitional provision in relation to the withdrawal of the United Kingdom from the European Union
33A
- (1) Subject to paragraphs (2) and (3), these Regulations do not apply to any activity which is covered by a written consent given by a competent authority of an EEA State in accordance with Article 15(3), 17(6) or 18(2) of Directive (EC) No 2001/18 of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the environment of genetically modified organisms.
- (2) The written consent referred to in paragraph (1) must be valid immediately before IP completion day.
- (3) Any activity covered by the consent referred to in paragraph (1) must be conducted in accordance with any obligations, conditions or limitations attached to that consent.
- (4) Subject to paragraphs (5) and (6), these Regulations do not apply to any genetically modified organisms which are cultured, stored, transported, destroyed, disposed of or used, where such organisms are, or are contained in, a medicinal product for human or veterinary use marketed in accordance with an authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency.
- (5) The marketing authorisation referred to in paragraph (4) must be valid immediately before IP completion day.
- (6) Any marketing authorisation referred to in paragraph (4) must be conducted in accordance with any obligations, conditions, restrictions, requirements or limitations attached to that authorisation.
Consequential amendments
Revocations
Reading this document does not replace reading the official text published on legislation.gov.uk. Contains public sector information licensed under the Open Government Licence v3.0. We assume no responsibility for any inaccuracies arising from the conversion of the original CLML XML to this format.
This text is published under legislation.gov.uk's own terms of reuse, not a Legalize or public-domain licence.
legislation.gov.uk
Open Government Licence v3.0 (attribution required)
© Crown and database right. Derived from content available under the Open Government Licence v3.0 from legislation.gov.uk.